Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization

Hypercholesterolemia is a recognized risk factor for development of atherosclerosis in both native coronary arteries and bypass grafts. Lipid-lowering therapy with statins is effective. Few data are available for studies on bypass grafts. The influence of hypercholesterolemia on development of bypas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular surgery (London, England) England), 2001-02, Vol.9 (1), p.33-43
1. Verfasser:	Christenson, J.T
Format:	Artikel
Sprache:	eng
Schlagworte:	angiography arterial anastomosis CABG Female follow up Follow-Up Studies Graft Rejection - prevention & control grafts Humans hypercholesterolemia Hypercholesterolemia - drug therapy Hypolipidemic Agents - therapeutic use internal thoracic artery lipids Male Middle Aged Myocardial Revascularization Preoperative Care Prospective Studies Risk Factors sequential Simvastatin - therapeutic use statins Time Factors veins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!